Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

Efficacy and Safety of SAGE-547 Injection in the Treatment of Super-Refractory Status Epilepticus

Efficacy and Safety of SAGE-547 Injection in the Treatment of Subjects With Super-Refractory Status

Description:

For complete study information, please visit clinicaltrials.gov.

Study Status:

Closed

IRB Study ID:

151016

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...